Shahararriyar Binciken Kimiyya ta gano cewa gwaje-gwajen antigen na gida guda bakwai na COVID-19 "mai sauƙin amfani ne" kuma "muhimmin kayan aiki don rage yaduwar cutar coronavirus"

Yuni 2, 2021 |Biyayya, Laifin Shari'a da Likita, Kayayyaki da Kayayyaki, Labarun Laboratory, Ayyukan Laboratory, Pathology na Laboratory, Gudanarwa da Ayyuka
Kodayake gwajin gwajin RT-PCR na asibiti har yanzu shine "ma'aunin zinare" lokacin da ake bincikar COVID-19, gwajin antigen na gida yana ba da sakamako mai dacewa da sauri.Amma sun yi daidai?
Kasa da watanni shida bayan Hukumar Abinci da Magunguna ta Amurka (FDA) ta ba Ellume izinin amfani da gaggawa ta farko (EUA) don gwajin gwajin cutar kanjamau na SARS-CoV-2 don gwajin antigen na gida na COVID-19, masu amfani da lambar. gwaje-gwajen da za a iya yi a gida sun girma isa ga mashahurin kimiyya don buga bita na kayan gwajin COVID-19 na mabukaci.
Dakunan gwaje-gwaje na asibiti da masu ilimin cututtuka gabaɗaya sun yarda cewa gwajin sarkar sarkar RT-polymerase (RT-PCR) har yanzu ita ce hanyar da aka fi so don gano cutar COVID-19.Koyaya, bisa ga rahotannin "Kimiyya Mashahuri", saurin gwajin antigen na gida wanda zai iya gano daidai mutanen da ke ɗauke da ƙwayoyin cuta masu yawa suna zama muhimmin kayan aiki don yaƙar yaduwar cutar ta coronavirus.
A cikin “Mun sake duba shahararren gwajin COVID-19 na gida.Wannan shine abin da muka koya: Akwai ƙarin zaɓuɓɓuka don gwajin gida don COVID, duk abin da kuke buƙatar sani, "Kwararren Kimiyya ya kimanta sauƙin amfani da tasiri na gwaje-gwaje masu zuwa:
Yawancin gwaje-gwajen gida na baya-bayan nan ba kawai damar masu amfani da su tattara nasu swabs ko samfuran miya ba, amma wasu kuma na iya samar da sakamako cikin ƙasa da sa'a guda, wanda za'a iya aikawa zuwa wayar mai amfani.Sabanin haka, kayan tattara kayan gida da aka dawo da su dakin gwaje-gwaje na asibiti don gwaji na iya ɗaukar sa'o'i 48 ko fiye don jigilar su da sarrafa su.
Mara Aspinall, farfesa a Makarantar Magance Lafiya ta Jami'ar Jihar Arizona, ta gaya wa Mashahuran Kimiyya: "Idan muka iya yin gwaje-gwaje masu sauƙi, na yau da kullun, a gida, ƙarancin buƙatar mu."Zai zama al'ada, mai sauƙi kamar goge haƙoranku," in ji ta.
Koyaya, a cikin "Masu Likitan cuta suna Buƙatar yin Hattara akan Kayan Gwajin COVID-19 a Gida", MedPage a yau ta ba da rahoton a cikin wani taron kafofin watsa labarai na kwale-kwale na Kwalejin Kwayoyin cuta ta Amurka (CAP) a ranar 11 ga Maris, yana nuna cewa COVID-19 a gida -19 Lalacewar ganowa.
Abubuwan da aka ambata sun haɗa da rashin isassun samfura da rashin kulawa da zai iya haifar da sakamako mara kyau, da rashin tabbas game da ko gwajin antigen a gida zai gano bambance-bambancen COVID-19.
Quest Direct da LabCorp Pixel gwaje-gwaje-duka ana aika su zuwa dakin gwaje-gwaje na kamfani don gwajin PCR-akan manyan alamomin ƙididdiga guda biyu na ƙwarewar aiki (yarjejeniyar kashi mai kyau) da ƙayyadaddun (yarjejeniyar kashi mara kyau) Maki mafi girma.Dangane da rahotannin "Kimiyya Popular", hankali da ƙayyadaddun waɗannan gwaje-gwajen sun kusan kusan 100%.
Mashahurin kimiyya ya gano cewa waɗannan gwaje-gwaje gabaɗaya suna da sauƙin amfani kuma sun kammala cewa kayan aiki ne masu amfani (idan ba cikakke ba) a cikin yaƙin COVID-19.
"Idan ba a yi muku allurar rigakafi ba kuma kuna da alamun cutar, hanya ce mai kyau don tabbatar da kamuwa da cutar ta COVID-19 ba tare da haɗarin fita ba," in ji Popular Science a cikin labarinta."Idan ba a yi muku alurar riga kafi ba kuma ba ku da alamun cutar kuma kawai kuna son sanin ko za ku iya shiga cikin liyafar cin abinci na iyali ko wasannin ƙwallon ƙafa cikin aminci, gwaji a gida har yanzu hanya ce ta tantance kai mara kyau.Ka tuna: idan sakamakon gwajin ba shi da kyau , Sakamakon na iya zama kuskure.Idan ba ku sanya abin rufe fuska ba, za a iya fallasa ku da gangan ga wasu mutane a cikin ƙafa shida na wasu. ”
Tare da shaharar gwajin COVID-19 a gida, dakunan gwaje-gwaje na asibiti da ke yin gwajin RT-PCR na iya son yin la'akari da buƙatun saurin gwajin antigen a gida, musamman yanzu da ake samun wasu gwaje-gwaje ba tare da takardar sayan magani ba.
Sabuntawar Coronavirus (COVID-19): FDA ta ba da izinin gwajin antigen azaman farkon kan-da-counter, gwajin gwajin gida gaba ɗaya don COVID-19
Ayyuka da Samfura: Webinars |Farar Takardu |Shirye-shiryen Abokin Ciniki mai yuwuwar |Rahotanni na Musamman |Abubuwan da suka faru |E-wasiƙun labarai


Lokacin aikawa: Juni-25-2021